| Term 
 
        | HAART (Highly active antiretroviral therapy) |  | Definition 
 
        | -combination therapy -NRTI (nucleotide reverse transcriptse inhibitors -NNRTI (nonnucleotide reverse transcriptase inhibitor -PI (protease inhibitor) -drug resistance is a challenge |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - decreases viral load to undetectable -stabilizes or increases # of CD 4 + T cells -reduce incidence of opportunistic infections -minimize SE of antiviral therapy -improve quality of life, survival |  | 
        |  | 
        
        | Term 
 
        | NRTI (nucleotide reverse transcriptase inhibitors) |  | Definition 
 
        | -block viral -SE: hepatic steatosis (fatty) -lipoatrophy, peripheral neuropathy, pancreatitis, lactic acidosis, n/v/d can last 2 wk |  | 
        |  | 
        
        | Term 
 
        | *Zidovudine (Retrovir, AZT) |  | Definition 
 
        | -NRTI, treat HIV & prevent maternal-fetal HIV transmission -$6500/yr -dose: 200 mg po -SE: neuropathy, rash, pruritis, insomnia, confusion, bluish-brown bands on nails -Adverse: anemia, neutropenia, seizures -watch renal/hepatic issues |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | NRTI, HIV drug -take on empty stomach |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -NRTI, HIV drug -30-40 mg |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 
        | NNRTI (Non-nucleotide reverse transcriptase inhibitors) |  | Definition 
 
        | -prevent viral replication -drug resistance is a challenge |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -NNRTI, HIV drug -$7725/yr -dose: 600 mg at bedtime, increased absorption w/ high-fat meal -SE: dizzy, sedation, loss of concentration, nightmares, diarrhea -Adverse: convulsion, suicide, aggression, liver failure, neuropathy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -NNRTI, HIV drug -dose: 200 mg SE: rash, hepatotoxic, Steven-Johnson syndrome |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -act at end of HIV cycle to block production of HIV viruses -improved sustained viral response, improved survival |  | 
        |  | 
        
        | Term 
 
        | *Lopinavir/ritonavir (Kaletra) |  | Definition 
 
        | -PI, HIV drug -$11,000/yr -dose: 400 mg w/ food -SE: n/v/d, hyperglycemia -Adverse: DM -caution if hx of pancreatitis -drug-drug: azole antifungals, statins, St. John's wort |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -entry inhibitor, HIV drug -expensive -dose: 90 mg SQ SE: rash, diarrhea, injection site reaction |  | 
        |  | 
        
        | Term 
 
        | HIV/AIDS drugs Nursing Measures |  | Definition 
 
        | -asses for weight loss, chronic diarrhea -assess for immune suppression ie opportunistic infections (fever, malaise, thrush) -give emotional support -educate on transmission of virus -monitor adherence to med regimen -assess labs (CBC, CD4 counts) -hand washing |  | 
        |  |